Cost‐effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin‐exacerbated respiratory disease-Reference-Cited by-同舟云学术

Cost‐effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin‐exacerbated respiratory disease

Published:2021-07-26 Issue:12 Volume:11 Page:1626-1636
ISSN:2042-6976
Container-title:International Forum of Allergy & Rhinology
language:en
Short-container-title:Int Forum Allergy Rhinol.

Author:

Yong Michael¹^ORCID,Wu Yu Qi¹,Howlett Joel¹,Ballreich Jeromie²,Walgama Evan³,Thamboo Andrew¹

Affiliation:

1. Faculty of Medicine Division of Otolaryngology–Head and Neck Surgery University of British Columbia Vancouver BC Canada

2. Department of Health Policy and Management Johns Hopkins Bloomberg School of Public Health Baltimore MD

3. Division of Head & Neck Surgery, MD Anderson Cancer Center Houston TX

Publisher

Wiley

Subject

Otorhinolaryngology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alr.22865

Reference49 articles.

1. Daily cost of an intensive care unit day: The contribution of mechanical ventilation*

2. Update on Aspirin Desensitization for Chronic Rhinosinusitis with Polyps in Aspirin-Exacerbated Respiratory Disease (AERD)

3. Endoscopic Sinus Surgery for the Excision of Nasal Polyps: A Systematic Review of Safety and Effectiveness

4. European position paper on rhinosinusitis and nasal polyps 2020;Fokkens WJ;Rhinology,2020

5. Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Effectiveness of Dupilumab Versus Sinus Surgery for Chronic Rhinosinusitis With Polyps: Systematic Review and a Meta-Analysis;American Journal of Rhinology & Allergy;2024-08-16

2. Is the United Kingdom (UK) medicines pricing policy failing patients? The impact of terminated National Institute for Health and Care Excellence (NICE) appraisals for multi-indication products on patients;2024-08-07

3. History of Aspirin-Exacerbated Respiratory Disease: Discovery, Clinical Features, and Treatment;The Journal of Allergy and Clinical Immunology: In Practice;2024-08

4. The Burden of Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease: Interplay Between Quality of Life and Economic Implications;The Journal of Allergy and Clinical Immunology: In Practice;2024-07

5. Eosinophilic esophagitis in the era of biologics;Expert Review of Gastroenterology & Hepatology;2024-06-02